Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.31 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4318738 | 0.79 | HSD11B1 (0.36) | HSD11B1CYP1A2POLBCYP2C19ALDH1A1 | |
| SCHEMBL9875452 | 0.77 | GRM2 (0.43) | GRM2GRM5GRM1HSD11B1SLC6A12 | |
| SCHEMBL7872606 | 0.74 | GRM2 (0.47) | GRM2GRM5GRM1HSD11B1CYP1A2 | |
| SCHEMBL7235199 | 0.73 | — | — | |
| SCHEMBL11612533 | 0.71 | GRM2 (0.37) | GRM2GRM5GRM1HSD11B1CYP1A2 | |
| SCHEMBL189533 | 0.67 | POLB (0.48) | GRM1HSD11B1CYP1A2POLBCYP2C19 | |
| SCHEMBL30477996 | 0.67 | HSD11B1 (0.46) | GRM2GRM5GRM1HSD11B1POLB | |
| SCHEMBL8097478 | 0.66 | HSD11B1 (0.48) | HSD11B1POLBALDH1A1 | |
| SCHEMBL28259241 | 0.64 | GRM2 (0.40) | GRM2GRM5GRM1CYP1A2CYP2C19 | |
| SCHEMBL27502235 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | MITSUI CHEMICALS, INC. (JP) | 2025-12-02 | — | — | US | disclosed |
| EP-4435499-A2 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2024-09-25 | — | — | EP | disclosed |
| WO-2024005030-A1 | DIPHENYLETHENE-BASED COMPOUND, LIGHT ABSORBER, RESIN COMPOSITION, AND USE THEREOF | 山本化成株式会社 | 2024-01-04 | — | — | WO | disclosed |
| US-20220363650-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2022-11-17 | — | — | US | disclosed |
| EP-4032879-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2022-07-27 | — | — | EP | disclosed |
| EP-3611175-B1 | NAPHTHALOCYANINE COMPOUND, METHOD FOR PRODUCING SAME, AND USE THEREOF | YAMAMOTO CHEMICALS INC (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11174274-B2 | Naphthalocyanine compound, method for producing same, and use thereof | YAMAMOTO CHEMICALS, INC. (JP) | 2021-11-16 | — | — | US | disclosed |
| US-11015061-B2 | Phthalocyanine-based compound and uses of same | YAMAMOTO CHEMICALS, INC. (JP) | 2021-05-25 | — | — | US | disclosed |
| US-20210107924-A1 | NAPHTHALOCYANINE COMPOUND, METHOD FOR PRODUCING SAME, AND USE THEREOF | YAMAMOTO CHEMICALS, INC. (JP) | 2021-04-15 | — | — | US | disclosed |
| EP-3611175-A1 | NAPHTHALOCYANINE COMPOUND, METHOD FOR PRODUCING SAME, AND USE THEREOF | Yamamoto Chemicals, Inc. (JP) | 2020-02-19 | — | — | EP | disclosed |
| US-20200032066-A1 | PHTHALOCYANINE-BASED COMPOUND AND USES OF SAME | YAMAMOTO CHEMICALS, INC. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-7506977-B1 | Plastic spectacles lens | HOPNIC LABORATORY CO., LTD. (JP) | 2009-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107924-A1 | NAPHTHALOCYANINE COMPOUND, METHOD FOR PRODUCING SAME, AND USE THEREOF | MRPS9, INTS9, RPL19 | GRM2 4432/4885GRM5 4564/4885GRM1 4393/4885 |
| US-20220363650-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | SULT1A1, BET1, SULT1E1 | GRM2 2442/4885GRM5 2062/4885GRM1 805/4885 |
| US-11174274-B2 | Naphthalocyanine compound, method for producing same, and use thereof | MRPS9, INTS9, RPL19 | GRM2 4432/4885GRM5 4564/4885GRM1 4393/4885 |
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | SULT1A1, BET1, SULT1E1 | GRM2 2442/4885GRM5 2062/4885GRM1 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.